AdaptHealth (AHCO) - 56.66% Below 52-Week High: Buy or Wait?

Stock Details

AdaptHealth Corp. (AHCO), a prominent company in the healthcare sector within the medical devices industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $5.82. Over the past 52 weeks, it has ranged between $8.51 and $13.43. This places the current price at 43.3% of its 52-week high and -31.6% above its 52-week low. Recent trading volume was recorded at 17,646. The 14-day Relative Strength Index (RSI) stands at 71.03, suggesting overbought conditions. The stock is currently trading below its 50-day moving average of $10.72 by 45.71%. Similarly, it is below its 200-day moving average of $9.83 by 40.79%. The MACD histogram is 0.04, indicating bullish momentum (MACD Line: 0.60, Signal Line: 0.56).

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

9.26

Price to Book

0.95

EV/EBITDA

5.83

EPS (TTM)

-$0.59

Price to Sales

0.45

Beta

1.45

Similar volatility to market

Q:How is AHCO valued relative to its earnings and growth?

Valuation data is not available for this stock.

Q:What is AHCO's risk profile compared to the market?

With a beta of 1.45, AdaptHealth Corp. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 0.95 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

-2.42%

Operating Margin

0.67%

EBITDA

$582.61M

Return on Equity

-4.85%

Return on Assets

2.64%

Revenue Growth (YoY)

5.40%

Q:How profitable and efficient is AHCO's business model?

AdaptHealth Corp. achieves a profit margin of -2.42%, meaning it retains $-2.42 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 0.67% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -4.85% and ROA at 2.64%, the company achieves moderate returns on invested capital.

Q:What are AHCO's recent growth trends?

AdaptHealth Corp.'s revenue grew by 5.40% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. These growth metrics should be evaluated against Medical Devices industry averages for proper context.

Company Size & Market

Market Cap

$1.5B

Revenue (TTM)

$3.29B

Revenue/Share (TTM)

$24.28

Shares Outstanding

136.05M

Book Value/Share

$11.33

Asset Type

EQUITY

Q:What is AHCO's market capitalization and position?

AdaptHealth Corp. has a market capitalization of $1.5B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 136.05M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Medical Devices industry, it competes with other firms in this sector.

Q:How does AHCO's price compare to its book value?

AdaptHealth Corp.'s book value per share is $11.33, while the current stock price is $5.82, resulting in a price-to-book (P/B) ratio of 0.51. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$14.14

143.00% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

Q:How reliable are analyst predictions for AHCO?

8 analysts cover AHCO with 75% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $14.14 implies 143.0% upside, but targets are often adjusted to follow price moves rather than predict them.

Q:What is the Wall Street consensus on AHCO?

Current analyst recommendations:1 Strong Buy, 5 Buy, 2 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 2, 2026, 02:37 AM

Technical Indicators

RSI (14-day)

71.03

Overbought

50-Day Moving Average

$10.72

-45.71% below MA-50

200-Day Moving Average

$9.83

-40.79% below MA-200

MACD Line

0.60

MACD Signal

0.56

MACD Histogram

0.04

Bullish

Q:What does AHCO's RSI value tell investors?

The RSI (Relative Strength Index) for AHCO is currently 71.03, indicating the stock is in overbought territory (above 70). This suggests strong recent buying pressure that may be unsustainable. While overbought conditions can persist in strong trends, traders often watch for RSI divergences or a drop below 70 as potential sell signals. Combined with the price being below the 50-day moving average, this shows mixed signals requiring careful analysis.

Q:How should traders interpret AHCO's MACD and moving average crossovers?

MACD analysis shows the MACD line at 0.60 above the signal line at 0.56, with histogram at 0.04. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($10.72) is above the 200-day MA ($9.83), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently below both MAs, confirming weakness.

Indicators last updated: Apr 18, 2026, 12:49 AM

AdaptHealth Corp. (AHCO) Stock